ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

PYXS Pyxis Oncology Inc

3.94
-0.25 (-5.97%)
Last Updated: 12:16:08
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Pyxis Oncology Inc PYXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -5.97% 3.94 12:16:08
Open Price Low Price High Price Close Price Prev Close
4.15 3.89 4.22 4.19
more quote information »

Recent News

Date Time Source Heading
5/14/202408:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202407:55EDGAR2Form 8-K - Current report
5/14/202407:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
5/09/202407:30GLOBEPyxis Oncology to Present at the RBC Capital Markets Global..
3/28/202416:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
3/27/202407:30GLOBEPyxis Oncology Obtains $8 Million Payment for the Sale of..
3/21/202407:30GLOBEPyxis Oncology Provides Corporate Update and Reports..
3/13/202408:00GLOBEPyxis Oncology Expands Board of Directors with Appointment..
3/08/202416:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
3/07/202416:30GLOBEPyxis Oncology to Present at Leerink Global Biopharma..
3/05/202416:45GLOBEPyxis Oncology to Present New PYX-201, PYX-106 and PYX-102..
2/28/202407:02EDGAR2Form 8-K - Current report
2/27/202408:00GLOBEPyxis Oncology Announces $50 Million Private Placement
12/29/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/29/202316:30GLOBEPyxis Oncology Reports Inducement Grants Under Nasdaq..
12/06/202316:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/30/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202307:22EDGAR2Form 8-K - Current report
11/28/202307:00GLOBEPyxis Oncology Announces Appointment of Ken Kobayashi, M.D.,..
11/17/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202316:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202316:44EDGAR2Form 8-K - Current report
11/07/202316:30GLOBEPyxis Oncology Announces Initiatives to Prioritize Lead ADC..
10/27/202316:34EDGAR2Form 8-K/A - Current report: [Amend]
9/28/202316:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/27/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/27/202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/27/202309:18GLOBEPyxis Oncology Announces Four Abstracts Accepted for Poster..
9/25/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/22/202319:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/22/202319:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202317:08EDGAR2Form 144 - Report of proposed sale of securities
8/31/202316:01GLOBEPyxis Oncology to Participate in Two Upcoming Investment..
8/25/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/23/202317:30EDGAR2Form S-8 POS - Securities to be offered to employees in..
8/23/202317:28EDGAR2Form POS AM - Post-Effective amendments for registration..
8/23/202317:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/23/202308:47EDGAR2Form 8-K - Current report
8/23/202308:35GLOBEPyxis Oncology Successfully Completes Acquisition of..
8/11/202317:00EDGAR2Form 144 - Report of proposed sale of securities
8/11/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202307:26EDGAR2Form 425 - Prospectuses and communications, business..
8/11/202307:25EDGAR2Form 8-K - Current report
8/11/202307:00GLOBEPyxis Oncology Reports Financial Results for Second-Quarter..
8/11/202306:35EDGAR2Form 425 - Prospectuses and communications, business..
8/11/202306:34EDGAR2Form 8-K - Current report
8/01/202317:14EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock